Orig3n is a biotechnology research company. It helps people understand the links between their genes and how their minds and bodies work. Orig3n's DNA tests develop personalized therapies for repairing tissue damage and disease, leveraging cellular science.
|Employees (est.) (Nov 2020)||33||(+7%)|
Orig3n total Funding
Orig3n latest funding size
Time since last funding
|2 years ago|
|Vectr Ventures, KTB Ventures, DEFTA Partners, Hatteras Venture Partners, Mountain Group Capital, LabCorp, Syno Capital, Alexandria Venture Investments, 180 Degree Capital, Spectrum Health Ventures, KTB-KORUS Fund, MGC Venture Partners, Haitong International Securities Group, MMIC Investment Holdings|
|Company Name||Date||Deal Size|
|Interleukin Genetics||November 22, 2017|
Orig3n has 12.42k Twitter Followers. The number of followers has decreased 0.7% month over month and decreased 1.9% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was Orig3n founded?
Orig3n was founded in 2014.
Who are Orig3n key executives?
Orig3n's key executives are Kate Blanchard, Robin Smith and Marcie Glicksman.
How many employees does Orig3n have?
Orig3n has 33 employees.
Who are Orig3n competitors?
Competitors of Orig3n include Helix, Ancestry and MyHeritage.
Where is Orig3n headquarters?
Orig3n headquarters is located at 27 Drydock Ave 3rd Floor, Boston.
Where are Orig3n offices?
Orig3n has an office in Boston.
How many offices does Orig3n have?
Orig3n has 1 office.
Receive alerts for 300+ data fields across thousands of companies